Endocrine and clinical aspects of new compounds for treatment of hormone-related cancer in gynecology.
von Matthiessen
H
H
Universitäts-Frauenklinik, Düsseldorf, FRG.
Distler
W
W
D000616:Aminoglutethimide / Q000627:therapeutic use; D000735:Androstenedione / Q000031:analogs & derivatives / Q000627:therapeutic use; D047072:Aromatase Inhibitors; D001943:Breast Neoplasms / Q000188:drug therapy*; D002064:Buserelin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005260:Female; D017273:Goserelin; D006801:Humans; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy*; D013629:Tamoxifen / Q000031:analogs & derivatives / Q000627:therapeutic use*
D047072:Aromatase Inhibitors; D013629:Tamoxifen; D017273:Goserelin; D000616:Aminoglutethimide; D000735:Androstenedione; C014594:formestane; D002064:Buserelin